Jialun Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jialun Zhu has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Milla
Center for Excellence in Pulmonary Biology, Stanford University, Stanford, California, USA
2 shared publications - Jiawei Tan
Interconnected & Integrated Bioelectronics Lab (I2BL) Department of Electrical and Computer Engineering University of California Los Angeles CA 90095 USA
2 shared publications - Sam Emaminejad
University of California, Los Angeles (UCLA)
2 shared publications - Shuyu Lin
Interconnected & Integrated Bioelectronics Lab (I2BL) Department of Electrical and Computer Engineering University of California Los Angeles CA 90095 USA
2 shared publications - Xuanbing Cheng
Interconnected and Integrated Bioelectronics Lab (I2BL), Department of Electrical and Computer Engineering, Samueli School of Engineering, University of California, Los Angeles, Los Angeles, CA 90095,USA
2 shared publications - Yichao Zhao
David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
2 shared publications
Latest Publications
- 1 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (843) , eadr5493
Resilient nanostructured bioanalytic microneedle longitudinally monitors preclinical renal and hepatic drug clearance and dysfunction
Wearable microneedle biosensors promise real-time molecular monitoring for precision medicine but are limited by low sensitivity and tissue abrasion. Overcoming these challenges, we recast electrode functionality not merely as a sensing substrate but as a mechanism for resilient, high signal-to-noise ratio (SNR) measurements in tissue. Our microneedle-based resilient nanostructured bioelectrode (RNB) is fabricated using a bilayer process that strengthens the electrode with a micrometer-thick gold adhesion layer and reduces fabrication-induced stress through controlled dealloying. The resulting RNBs are corrosion resistant, stable over a wide potential window, and have an artifact-free, nanocavity-textured interface. They integrate receptor-based electrochemical biosensors with enhanced SNR through increased active area, diffusion, and antifouling while remaining abrasion immune in megapascal-stiff tissues. The RNB extended in vivo biosensor lifetime for pharmacokinetics monitoring to 6 days in a freely moving rat. Paired with a blood–interstitial fluid equilibrium–based bioanalytical framework, the RNB accurately derived blood-equivalent pharmacokinetic parameters, enabling not only precision dosing of narrow therapeutic index drugs but also the direct assessment of hepatic and renal clearance. In hepatic studies, the RNB revealed delayed clearance of a chemotherapeutic (irinotecan) in liver-damaged models. In renal studies, RNB recordings correlated with blood antibiotic pharmacokinetics across chronic kidney disease severities. The RNB detected renal impairment earlier than conventional biomarker thresholds through drug clearance quantification and captured recovery under therapeutic intervention. These results establish the RNB as a viable microneedle platform for high-fidelity in vivo deployment of electrochemical biosensors, enabling minimally invasive, longitudinal monitoring of low-concentration analytes and real-time assessment of organ function.
- 1 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (843) , eadr5493
Resilient nanostructured bioanalytic microneedle longitudinally monitors preclinical renal and hepatic drug clearance and dysfunction
Wearable microneedle biosensors promise real-time molecular monitoring for precision medicine but are limited by low sensitivity and tissue abrasion. Overcoming these challenges, we recast electrode functionality not merely as a sensing substrate but as a mechanism for resilient, high signal-to-noise ratio (SNR) measurements in tissue. Our microneedle-based resilient nanostructured bioelectrode (RNB) is fabricated using a bilayer process that strengthens the electrode with a micrometer-thick gold adhesion layer and reduces fabrication-induced stress through controlled dealloying. The resulting RNBs are corrosion resistant, stable over a wide potential window, and have an artifact-free, nanocavity-textured interface. They integrate receptor-based electrochemical biosensors with enhanced SNR through increased active area, diffusion, and antifouling while remaining abrasion immune in megapascal-stiff tissues. The RNB extended in vivo biosensor lifetime for pharmacokinetics monitoring to 6 days in a freely moving rat. Paired with a blood–interstitial fluid equilibrium–based bioanalytical framework, the RNB accurately derived blood-equivalent pharmacokinetic parameters, enabling not only precision dosing of narrow therapeutic index drugs but also the direct assessment of hepatic and renal clearance. In hepatic studies, the RNB revealed delayed clearance of a chemotherapeutic (irinotecan) in liver-damaged models. In renal studies, RNB recordings correlated with blood antibiotic pharmacokinetics across chronic kidney disease severities. The RNB detected renal impairment earlier than conventional biomarker thresholds through drug clearance quantification and captured recovery under therapeutic intervention. These results establish the RNB as a viable microneedle platform for high-fidelity in vivo deployment of electrochemical biosensors, enabling minimally invasive, longitudinal monitoring of low-concentration analytes and real-time assessment of organ function.
- 22 April 2023
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (14)
Non‐Invasive Touch‐Based Lithium Monitoring Using an Organohydrogel‐Based Sensing Interface
Lithium is a drug widely employed for the treatment of bipolar disorder owing to its high efficacy in mood management and suicide prevention. However, this efficacy is often undermined by misdosing and nonadherence, and diligent drug monitoring is required during treatment. Standard lithium monitoring involves invasive blood collections and laboratory analysis with low time granularity. Recent advances in sensor technology have enabled the development of personalized drug‐monitoring devices that analyze biomarker information noninvasively. Herein, based on the fact that the analyte partition onto the fingertip with a high flux, a touch‐based noninvasive monitoring modality for managing lithium pharmacotherapy is devised. The system is built based on a thin organohydrogel‐mounted lithium ion‐selective electrode (TOH‐ISE). The TOH coating provides a stable environment for sensing. Through the utilization of a water/glycerol bi‐solvent matrix, the gel exhibits dehydration‐resist properties, rendering a controlled micro‐environment for ISE conditioning, and subsequently minimizing signal drift. To illustrate the clinical application of the solution, the system is tested on a subject prescribed lithium. The system successfully detected the increase in circulating drug levels following medication intake. Collectively, the results indicate the devised solution is capable to facilitate lithium adherence monitoring and has broader potential for optimizing lithium pharmacotherapy.
- 22 April 2023
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (14)
Non‐Invasive Touch‐Based Lithium Monitoring Using an Organohydrogel‐Based Sensing Interface
Lithium is a drug widely employed for the treatment of bipolar disorder owing to its high efficacy in mood management and suicide prevention. However, this efficacy is often undermined by misdosing and nonadherence, and diligent drug monitoring is required during treatment. Standard lithium monitoring involves invasive blood collections and laboratory analysis with low time granularity. Recent advances in sensor technology have enabled the development of personalized drug‐monitoring devices that analyze biomarker information noninvasively. Herein, based on the fact that the analyte partition onto the fingertip with a high flux, a touch‐based noninvasive monitoring modality for managing lithium pharmacotherapy is devised. The system is built based on a thin organohydrogel‐mounted lithium ion‐selective electrode (TOH‐ISE). The TOH coating provides a stable environment for sensing. Through the utilization of a water/glycerol bi‐solvent matrix, the gel exhibits dehydration‐resist properties, rendering a controlled micro‐environment for ISE conditioning, and subsequently minimizing signal drift. To illustrate the clinical application of the solution, the system is tested on a subject prescribed lithium. The system successfully detected the increase in circulating drug levels following medication intake. Collectively, the results indicate the devised solution is capable to facilitate lithium adherence monitoring and has broader potential for optimizing lithium pharmacotherapy.
- 1 May 2014
- Published by American Scientific Publishers in Journal of Nanoscience and Nanotechnology
- Vol. 14 (5) , 3840-3843
Enhancement of the Short Wavelength Upconversion Emission in Inverse Opal Photonic Crystals
Upconversion luminescence properties of Yb–Tb codoped Bi4Ti3O12 inverse opals have been investigated. The results show that the upconversion emission can be modulated by the photonic band gap. More significantly, in the upconversion inverse opals, the excited-state absorption of Tb3+ is greatly enhanced by the suppression of upconversion spontaneous emissions of the intermediate excited state, and thus the short wavelength upconversion emission from Tb3+ is considerably improved. We believe that the present work will be valuable for not only the foundational study of upconversion emission modifications but also new optical devices in upconversion displays and short wavelength upconversion lasers.
- 1 May 2014
- Published by American Scientific Publishers in Journal of Nanoscience and Nanotechnology
- Vol. 14 (5) , 3840-3843
Enhancement of the Short Wavelength Upconversion Emission in Inverse Opal Photonic Crystals
Upconversion luminescence properties of Yb–Tb codoped Bi4Ti3O12 inverse opals have been investigated. The results show that the upconversion emission can be modulated by the photonic band gap. More significantly, in the upconversion inverse opals, the excited-state absorption of Tb3+ is greatly enhanced by the suppression of upconversion spontaneous emissions of the intermediate excited state, and thus the short wavelength upconversion emission from Tb3+ is considerably improved. We believe that the present work will be valuable for not only the foundational study of upconversion emission modifications but also new optical devices in upconversion displays and short wavelength upconversion lasers.